Deciphering the innate mechanisms governing the blockade of proliferation in adult cardiomyocytes (CMs) is challenging for mammalian heart regeneration. Despite the exit of CMs from the cell cycle during the postnatal maturation period coincides with their morphological switch to a typical adult rod-shape, whether these two processes are connected is unknown. Here, we examined the role of ephrin-B1, a CM rod-shape stabilizer, in adult CM proliferation and cardiac regeneration.
Introduction
In the recent years, reinitiating the proliferative activity of differentiated resident cardiomyocytes (CMs) has emerged as an exciting avenue for cardiac regenerative medicine 1 . Theoretically, this challenging concept could provide the opportunity to yield sufficient CMs to replace their profuse loss after myocardial damage. Several studies have supported the natural self-renewal potential of mammalian adult CMs, but this mechanism has remained too weak to efficiently repair the heart [2] [3] [4] . Thus, strategies now focus on boosting this regenerative process by exploiting factors specifically involved in the early CM proliferation arrest during the postnatal period [5] [6] [7] [8] [9] , and they have succeeded in extending the neonatal regenerative window. In addition, several studies have recently explored the adult stage and identified factors allowing for adult CM proliferation, as well as heart regeneration, despite low proliferation rates 5, [10] [11] [12] [13] [14] [15] [16] . However, in the absence of cardiac injury, these studies did not report the in vivo consequences of the modulated factor on CM proliferation at baseline, or showed constitutive CM proliferation, most likely reflecting a functional compensatory mechanism and precluding these factors as bona fide targets for future clinical regenerative therapies. Hence, identification of the natural molecular mechanisms governing the postmitotic state of adult CMs remains a crucial issue.
In situ, mammalian CMs stop dividing around postnatal day 7 (P7), consistent not only with the P1-P7 regenerative cardiac window in neonatal mice 17 but also with the extinction of growth factors 10, 16, 18 , CM cell cycle regulators 15, 19 and cell growth pathways 20 . Interestingly, the exit of CMs from the cell cycle during the postnatal maturation period also coincides with a morphogenesis step during which the CM switches from a round-shape to a mature rodshape 21 . This polarization process of the CM, reminiscent of the polarity in epithelial cells, results in an asymmetric organization of plasma membrane components underlying specific functions, i.e. the intercalated disk involved in direct CM-CM longitudinal interactions and the lateral membrane connected to the basement membrane and the extracellular matrix (ECM). Until now, the molecular events leading to the establishment of the CM rod-shape remain unknown. Despite cell polarization and proliferation generally are generally considered as antagonistic processes, whether adult CM morphology and proliferation arrest might be directly connected has never been explored.
Recently, we identified the transmembrane protein ephrin-B1, a member of the large family of eph receptors/ephrin ligands 22 , as a new constituent of the adult CM lateral membrane and acting as a stabilizer of the adult CM rod-shape. We demonstrated that this protein acts independently of the costamere structure at the lateral membrane in agreement with the lack of contractile defects in young adult efnb1 knockout (KO) mice 23 . Ephrin-B1 does not directly contribute to the establishment of the adult CM rod-shape, i.e., the asymmetry of the surface membrane. However, it participates in the maturation of the adult CM polarity since we showed that it stabilizes this specific morphology through a physical stretching of the lateral membrane, which is essential for the overall cardiac tissue cohesion in adult mice. Accordingly, mice with global (KO) or CM-specific (cKO) efnb1 deletion display a soft cardiac tissue with an architectural disorganization of the CM lateral membrane leading to spindle-shaped, immature-like CMs. Interestingly, while 2-month-old efnb1 KO mice exhibit cardiac tissue disorganization, they do not develop cardiac failure in homeostatic conditions which was quite surprising given the importance of the tissue cohesion in the stabilization of the cardiac function. Nevertheless, they were intolerant to cardiac mechanical stress, in agreement with the lack of tissue cohesion. Here, we now questioned about a potential role for ephrin-B1 in the adult CM proliferation state that could reconcile the loss of the adult CM rod-shape and tissue cohesion to the standard cardiac function in young adult efnb1-KO mice.
Results

Ephrin-B1 postnatal expression correlates with the setting of the CM rodpolarity and the CM proliferation arrest
To investigate whether ephrin-B1 could regulate CM proliferation, we first examined its expression in the cardiac tissue at the postnatal stage during which the CM stop to proliferate. Ephrin-B1 protein expression picked at postnatal day 5 (Figure 1A) , a time point that correlated with the initiation of ephrin-B1 targeting to the CM lateral membrane (Figure 1B) but also with the CM cell cycle withdrawal 24 . Interestingly, the setting of ephrin-B1 at the CM lateral membrane paralleled the onset of the CM adult rod-shape (Figure 1C) with the different components structuring the different domains of the polarized plasma membrane, i.e. the lateral membrane (-sarcoglycan) with its basement membrane (laminin 2), Supplementary material online, Figure S1A ) and the ID (N-Cadherin, Zo-1, Supplementary material online, Figure S1B ). At early postnatal stages, ephrin-B1 expression predominated in CM nuclei, which persisted until the adult stage (Figure 1B) .
Ephrin-B1 blocks proliferation-competence to adult CMs
We next examined the role of ephrin-B1 in the adult CM proliferation. For that purpose, we first assessed the global CM proliferation in the hearts from 2-month-old adult efnb1 cKO mice (CM-specific KO) using immunostaining for Ki67, a marker of all active phases of the cell cycle (G1, S, G2, M). While substantial Ki67-positive CM nuclei were observed in heart tissues from postnatal P2 mice, we did not detect any Ki67 positive staining in the CMs from cKO or WT mice (Supplementary material online, Figure S2A ). This result most likely indicated that the absence of ephrin-B1 in the adult CM does not promote constitutive CM proliferation at resting state. Given that both CM proliferation or hypertrophy occur as compensatory mechanisms to meet the increased functional demand of the heart, the lack of constitutive CM proliferation in the absence of ephrin-B1 in young mice hearts is consistent with the lack of functional contractile defect in 2-month-old efnb1 cKO mice that we previously reported 23 .
However, the lack of CM proliferation events in vivo does not necessarily mean that efnb1 cKO CMs cannot proliferate. To explore this possibility, we assessed in vitro the potential proliferation-competent signature of CMs isolated from 2-month-old efnb1 cKO mice. The purity of the isolated CMs was controlled and reached about 80 % in all cases (not shown). We first examined the CM nucleation profile since several studies have demonstrated that mononucleated CMs have a higher proliferation propensity than binucleated one 12 . In agreement, at young adulthood (P60, 2 months old), cKO hearts harbored increased number of mononucleated CMs with, conversely, relatively fewer binucleated CMs but also an increased number of tri-and quadri-nucleated CMs, compared with WT (Figure 2A,  Supplementary material online, Figure S2B ). This defect in CM nucleation from adult cKO mice was even more evident when examining the postnatal cardiac maturation (P10 and P20) during which CMs progressively lose their proliferative aptitude (Figure 2A , Supplementary material online, Figure S2B) . Moreover, and consistent with a previous report demonstrating the role of miR-195 as a specific mitotic blocker of adult CMs 8 , we also found a dramatic decrease in miR-195 expression in CMs isolated from 2-month-old cKO mice (Figure 2B) , further reinforcing the proliferative potential of these mice at resting state.
We next determined directly whether the proliferative potential of CMs isolated from young adult efnb1 cKO could be mobilized upon exposure to neuregulin-1 (NRG-1), a growth factor able to promote adult CM proliferation 11 . In vitro, 8-day culture of 2-month-old WT and cKO CMs, in the presence of recombinant human NRG-1, resulted in low but detectable bromodeoxyuridine (BrdU) uptake in WT CMs (0.17±0.07 %), in agreement with a previous report 11 , while the percentage of replicative CMs considerably increased in cKO cells (9.57±0.70 %) ( Figure 2C) . Further supporting CM proliferation, CMs from cKO hearts also exhibited a substantially higher frequency than WT of mitosis (pH3 + , Figure 2D ) and cytokinesis (aurora kinase B + cleavage furrows, Figure 2E ) events. Proliferation signature of NRG-1-treated CMs from efbn1 cKO mice was reinforced by: i. morphological observations showing myofibril delocalization at the CM periphery as previously reported 7, 11, 25 and additional nuclear rounding and delocalization in numerous cKO CMs (Supplementary material online, Figure S2C ), and ii. in agreement with Sadek et al 26 , epigenetic analysis, showing a majority of CMs with diffuse DNA-euchromatin (Supplementary material online, Figure S2D ), consistent with the presence of gene activating-acetylated H3K9/14Ac (Supplementary material online, Figure S2E ), in contrast to major DNA-containing foci indicative of heterochromatin in NRG-1-untreated cKO CMs (Supplementary material online, Figure S2D ) and correlating with the expression of gene silencing-methylated H3K9me3 (Supplementary material online, Figure S2E ). The capacity of adult CMs from efnb1 cKO mice to proliferate in response to NRG-1 did not arise from CM adaptation that could have occurred during the postnatal maturation, but truly reflected a specific role of ephrin-B1 at the adulthood. Indeed, lentiviral-based efnb1 deletion but performed in isolated adult WT CMs also led to reactivation of the cell cycle and proliferation but only following NRG-1 stimulation (Figure 2F and G) , as observed in the transgenic efnb1 cKO model. Finally, NRG-1-induced CM proliferation was confirmed in vivo upon NRG-1 injection in 2-monthold mice (Supplementary material online, Figure S3A ). NRG-1 treatment did not impact cardiac function (Figure S3B) (Figure S3F ) in cKO mice compared to WT. Mitosis of resident CMs was qualitatively confirmed by nuclear co-staining of Aurora-B with pericentriolar material protein PCM1 (Aurkb + /PCM1 + cells), a specific CM nuclear marker (Figure S3G) , despite CM proliferation undervaluation using this marker (Figure S4) .
Overall, these results demonstrate that ephrin-B1 naturally blocks the proliferation potential of resident adult CMs.
Ephrin-B1 deletion in CMs promotes cardiac regeneration following apectomy in adult mice
To determine whether the proliferation potential of adult CMs lacking ephrin-B1 could be mobilized and ultimately contribute to cardiac regeneration in vivo, a natural process restricted to lower vertebrates 27 , we challenged efnb1 cKO mice using the radical surgical model of apectomy 28 at non-regenerative adulthood (2-month-old). WT or cKO mice underwent similar surgical and calibrated resection of the left ventricle apex (See Methods, Figure 3A , Supplementary material online, Figure S5A and B) . As expected, 21 days after apectomy, analysis of HE-and Trichrome-stained heart cross-sections from WT mice clearly showed a significant fibrotic scar replacing the excised tissue area (Figure 3B and C, Supplementary material online, Figure S5C ) devoid of CMs (Figure 3D) , with a disorganized vasculature ( Figure 3E) . Intriguingly, the resected apex in cKO hearts was replaced by almost normal myocardial tissue with the remarkable presence of a large number of CMs compared to WT (Figure 3B and D) , considerably reduced fibrosis (-50 %, Figure 3C ) and highly organized microvasculature ( Figure 3E ). Some CMs detected in the resected area of cKO hearts had reentered the cell cycle and undergone cell division, as indicated by the significant increase of CMs (TroponinT + or PCM1 + cells) positive for BrdU (replication; Figure 3F ), nuclear aurora kinase B (mitosis; Figure 3G and H) and aurora kinase B in the cleavage furrows (cytokinesis; Figure 3I ). CM proliferation in cKO mice was not restricted to the resected tissue area. Indeed, a significantly larger number of smaller (Supplementary material online, Figure S5D and E) and BrdU-or aurora kinase B-positive CMs was identified at the border of the resected area but also at distance in both the ventricles and the septum (Supplementary material online, Figure S5F and G). These findings suggest that the apex resection promoted a global tissue response, most likely to compensate for the dynamic ventricular systolic twist defect, in which the apex plays a fundamental role 29 . The cardiac tissue regeneration detected in the efnb1 cKO mice was consistently associated with a lesser cardiac dysfunction as assessed by echocardiographic left ventricular ejection fraction ( Figure 3J ) and global longitudinal strain ( Figure 3K) .
Overall, these results indicated that ephrin-B1 is a natural blocker of adult CM proliferation in vivo that prevents adult cardiac tissue regeneration.
AAV9-based-Ephrin-B1 knockdown in adult mice hearts promotes cardiac regeneration following myocardial infarction
From a better translational therapeutic perspective, we next determined whether efnb1 deficiency could similarly boost myocardial repair after myocardial infarction (MI). However, we could not use the efnb1cKO genetic model since these mice were highly prone to death compared to WT after MI (Supplementary material online, Figure S6A) , reflecting a higher susceptibility to cardiac mechanical stress, as we previously reported 23 . To bypass this problem and to preserve CM adhesion which requires Ephrin-B1 (Supplementary material online, Figure S7 ), we deleted Ephrin-B1 after the MI induction, based on an adenoassociated virus (AAV) serotype 9-delivery strategy with high cardiac tropism and long-term expression. Two-month-old C59/BL6 mice underwent permanent ligation of the left anterior descending coronary artery and, 3 days post-MI, mice exhibiting 30-40 % left ventricular ejection fraction were selected and immediately injected retro-orbitally with an AAV9 vector expressing shmiRefnb1 or a control vector (AAV9-mCherry) (Figure 4A, B) . Efficiency of Ephrin-B1 knockdown was successfully validated in vitro but also in vivo in the heart at the end of the protocol (Supplementary material online, Figure S6B, C) . As shown in Figure 4C , efnb1 knock-down considerably favored immediate and long-term mouse survival up to 56 days after AAV9 infection compared to control. Left ventricular ejection fraction (LVEF) was significantly stabilized 56 days post-MI in infarcted mice upon efnb1 knock-down (AAV-shmiRefnb1) with some animals exhibiting full LVEF restoration compared to control infarcted mice (AAV-mCherry) that functionally decompensated over time (Figure 4B , Supplementary material online, Figure S6D ). Histological analysis of the whole hearts showed a significant fibrosis reduction (40 %) in AAV9-shmiRefnb1 infected mice ( Figure  4D) , indicative of an infarct scar size reduction. The increase in heart weight-to-tibia length ratio after MI compared to sham was also significantly higher in these mice, suggesting higher hypertrophy compensation ( Figure 4E ). However, 56 days after efnb1 knockdown, analysis of the left ventricle (LV) remote zone in the MI group indicated the presence of smaller CMs compared to control AAV9 infection ( Figure 4F ) and the presence of mitotic troponin T-( Figure 4G ) or PCM1-( Figure 4H ) positive CMs also undergoing cytokinesis (Figure 4I) , most likely supporting cardiac compensation through resident CM proliferation. It is noteworthy that CM proliferation could also be measured at distance from the injury site in the septum (Supplementary material online, Figure S6E, F) . In all cases, LVEF in AAV9infected mice negatively correlated with fibrosis and CM area (Supplementary material online, Figure S6G, H) .
All together, these data indicate that cardiac deletion of Ephrin-B1 immediately after MI is beneficial for cardiac function by promoting resident CM proliferation and thus cardiac regeneration.
Efnb1 KO mice compensate for cardiac senescence through resident CM proliferation.
Despite we did not detect CM proliferation in young adult 2-month-old efnb1 cKO mice, we finally investigated the long-term consequences of efnb1 deletion, by examining the cardiac phenotype of 12-month-old efnb1 KO mice. In fact, given that we previously reported that the cardiac tissue disorganization was only focal at 2 month of age 23 , we hypothesized that it could generalize over lifetime and could ultimately lead to cardiac contractile function defect, thus offering the opportunity to use the proliferation potential of efnb1-KO CMs as a compensatory mechanism. At the tissue level, as expected, the absence of ephrin-B1 promoted a general disorganization of cardiac tissue architecture, including the loss of the rod-shape of adult CMs (Figure 5A ) in all heart compartments (Supplementary material online, Figure S8A) , with the presence of whorled CMs in some tissue areas (Supplementary material online, Figure S8B ), without fibrosis ( Figure 5B) . Both wild-type (WT) and KO aged mice similarly reactivated the fetal gene program indicative of cardiac hypertrophy remodeling (Figure 5C) , most likely reflecting a compensatory mechanism for aging stress, as suggested by the specific and substantial breakdown of TGF3 inflammatory gene expression ( Figure 5D ), a marker of cardiac senescence 30 . Intriguingly, while only a modest septal hypertrophy could be detected in aged WT mice (IVSTD, Figure 5E ), KO mice compensated through a more pronounced septum and left ventricle hypertrophy (Figure 5E ), but without alteration of the contractile function in both genotypes (Figure 5F) . Accordingly, old KO mice exhibited a mild but significant increase in heart/body weight ratio, compared to age-matched WT mice ( Figure  5G) . At the cellular level, 3D-stereology-based analysis confirmed 2-D heart cross-section analysis (Supplementary material online, Figure S9A ) and revealed a significantly higher CM density ( Figure 5H ) and a reduction in CM volume in old KO mice ( Figure 5I ) compared to their WT counterparts, for which the results were consistent with previous reports when considering age and strain genetic background (see Methods). Overall, these results demonstrated that adult efnb1 KO mice compensated for aging stress through atypical CM hyperplasia, thereby evoking proliferation.
The specific capability of adult CMs to proliferate during aging in the absence of ephrin-B1 was confirmed both in situ and in vitro (see Methods). First, in the cardiac tissue, the use of two different specific CM markers (cardiac troponin T, cTnT; or pericentriolar material protein PCM1) indicated substantial co-staining with mitosis (nuclear aurora kinase B-Aurkb + /DAPI + ) or cytokinesis (aurora kinase B-Aurkb + /cleavage furrows + ) markers ( Figure 5J and K; Supplementary material online, Figure S9B ). Second, in isolated CMs (~ 80 % purity) from aged mice, a notable induction of CM-specific proliferation marker gene expression 26, 31 from all phases of the cell cycle was found only in KO mice (Supplementary material online, Figure S9C ). Finally, flow cytometry analysis of propidium iodide-stained nuclei isolated from purified CMs showed a significant number of aged KO CMs in the DNA replicative S-phase ( Figure 5L ; 13 .50±3.05 %), compared to 2-and 12-month-old WT or 2month-old KO mice that were instead blocked in the G0/G1-and G2/M-phases, as expected due to their post-mitotic state 25 . These results were confirmed in old CM-specific-KO mice (cKO, Figure 5L ; 7.20 ± 0.91 %), thus precluding the contribution of other cell types to this process and clearly validating adult CM proliferation in the absence of ephrin-B1. Noteworthy, DNA replication, mitosis or cytokinesis cell cycle events were not detected in CMs from young 2-month-old KO mice (Figure 5L) , thus indicating a specific adaptation of efnb1 KO mice over time, most likely to compensate for aging stress, and not a constitutive CM proliferation phenotype of the efnb1 KO mice at birth as previously demonstrated.
Ephrin-B1 sequesters Yap1 at the lateral membrane to prevent adult CM proliferation
We next sought to understand the molecular mechanisms supporting ephrin-B1 as a suppressor of adult CM proliferation. Given its importance in the control of CM proliferation 32 , we examined the Hippo pathway in the 2-month-old efnb1 cKO mice and more specifically its core effector, Yap1. Yap1 gene (Figure 6A) or Yap1 protein expression and activity (phosphorylation state, P-Yap) (Figure 6B ; specificity of Yap1 immunostaining in western-blot was assessed as shown in Supplementary material online, Figure S10 ) were similar in CMs from resting young cKO or WT mice, with predominance of inactive P-Yap1, thus corroborating the absence of constitutive CM proliferation in efnb1 cKO mice at resting state. In tissue from WT mice, inactive P-Yap1 was expressed not only at the CM intercalated disk but also at the lateral membrane (Figure 6C) , where it colocalized with ephrin-B1 ( Figure 6D) . In contrast, in cKO mice, while still expressed in the intercalated disk, P-Yap1 was absent at the lateral membrane, and heterogeneous cytosolic P-Yap1 staining could be observed (Figure 6C , transversal view). Given that neither Yap1 global expression nor its activation state were modified in CMs from cKO mice, these results indicated that P-Yap1 was delocalized from the lateral membrane to the cytosol in the absence of ephrin-B1. Noticeably, active Yap1 was absent from CM nuclei (Supplementary material online, Figure  S11 ), in agreement with a lack of CM proliferation in resting cKO mice. The effect of efnb1 deletion on P-Yap1 delocalization is direct, since P-Yap1 coimmunoprecipitated with ephrin-B1 in WT CMs (Figure 6E) . The propensity of Yap1 to interact with ephrin-B1 was further confirmed by BRET-based experiments measuring direct protein-protein interactions in real time, in living HEK293T cells (see Methods; Figure 6F ). Altogether, our results showed that CMs from efnb1 cKO mice harbored a new cytosolic pool of delocalized inactive P-Yap1 that might be mobilized and thus offer a potential for proliferation under stress through Yap1 activation and nuclear translocation. We validated this hypothesis both in vitro and in vivo since NRG-1, aging and apectomy stimuli significantly promoted Yap1 nuclear translocation (Figure 6G-I) , as well as the expression of the Yap1-specific proliferation gene target 33 (Figure 6J) , only in CMs from cKO. Taken as a whole, these data indicate that ephrin-B1 sequesters inactive P-Yap1 at the lateral membrane of adult CMs, thereby preventing stimulus-promoted Yap-dependent proliferation of CMs.
Thus, our observations uncovered a new link between determinants of the adult CM morphology and CM proliferation.
Discussion
Despite early proliferation arrest of the CM during postnatal maturation coinciding with the establishment of its typical adult rod-shaped morphology, whether these two processes are interconnected is totally unknown. Here, we demonstrated for the first time an essential and dual role of ephrin-B1 in coordinating the morphology and proliferation of the adult CMs by a mechanism relying on a ephrin-B1 scaffolding inactive P-Yap1 at the lateral membrane and thereby controlling the post-mitotic state of this cell (Figure 7) . In the absence of ephrin-B1, inactive P-Yap1 is released into the cytosol. Under cardiac stress stimuli (apectomy, MI, aging), cytosolic P-Yap1 can then be activated, leading to its translocation into the nucleus to promote transcription of proliferation genes. Ultimately, this signaling cascade leads to striking cardiac compensation through CM proliferation and heart regeneration.
A major finding of our study was the lack of CM proliferation at resting state in the absence of ephrin-B1 while a substantial proliferation could be triggered to compensate for various cardiac stresses (apectomy, MI, senescence). This observation most likely supports a role for the ephrin-B1-Yap1 pathway as a natural sarcolemmal fine tuner of adult CM proliferation. Consistent with this assumption, re-expression in adult CMs of cell cycle cyclin genes that are naturally downregulated during the CM postnatal maturation was recently shown to lead to up to 15-20 % of CM division following myocardial infarction 34 . Interestingly, CM cytokinesis measured in the aged efnb1 KO mice also correlated with cyclin re-expression in these cells (Supplementary material online, Figure S8C ), in agreement with a vigorous revival of cell cycle progression and high CM proliferation rates in this model. Thus, ephrin-B1 could act as a natural blocking agent of cyclins during the postnatal maturation since ephrin-B1-Yap1 complex expression at the CM lateral membrane coincides with cyclin shutdown and CM proliferation arrest.
In these last few years, the Hippo pathway has been identified as a master regulator of CM proliferation and inactivating the Hippo pathway or activating its effector Yap1 at the adult stage substantially reactivated CM proliferation and cardiac repair after injury 6, 13, 35, 36 . Despite the molecular mechanisms governing the Hippo signaling specifically in the adult CM remaining poorly understood, compartmentalization of Yap1 has emerged recently. Thus, adherent CM junction Fat4 was shown to spatially sequester amotl1-Yap1 and to inhibit Yap activity, thus preventing CM proliferation at neonatal stage, but its role in the adult stage remains unknown 37 . Specific ablation of E/T-catenin in adult CMs had no impact on the CM proliferation state in unstressed hearts but favored cardiac regeneration after myocardial infarction through CM proliferation and Yap nuclearization 14 , emphasizing a fundamental role of the intercalated disk for Yap availability in the adult CM, but one that is mechanistically unknown. More recently, dystroglycan 1, a component of the DGC complex, localized at the lateral membrane of adult CMs and connecting the ECM and the contractile apparatus, was identified as a new, direct partner and repressor of Yap activity since mice with inactive DGC (Mdx mice) constitutively promoted CM proliferation through a Yap-dependent pathway 38 . In contrast, we demonstrated here new, original regulation of the Hippo pathway at the CM lateral membrane, relying on the spatial sequestration of inactive P-Yap1 by ephrin-B1 with no impact on its activity. This result provides a new level of information to understand the incompetence of the adult CM to proliferate relative to the Hippo pathway since, up to now, it has been related to the activation of the Hippo pathway and inactivation of its effector, Yap1.
Here, we demonstrated that the single spatial sequestration of inactive P-Yap1 at the lateral membrane could prevent its activation for further downstream proliferative signaling events. These results revealed the coexistence of multiple Hippo pathways at the lateral membrane of the adult CM. Consistently, we previously characterized ephrin-B1 as a new protein of the lateral membrane acting independently from the DGC or integrin systems but also from the contractile apparatus 23 . In these last few years, similar Yap subcellular sequestration has emerged as a new, original mechanism to regulate the Hippo pathway in other models 39 . Moreover, different Yap-dependent signaling pathways have been shown to coexist in the same cell 40 , highlighting the complexity of this system. Similar complexity does apply to the adult CM.
How can we now reconcile ephrin-B1 and Yap1 interaction from a structural standpoint? Ephrin-B1 can signal through its intracellular domain, which can recruit various signaling proteins through both PDZ-and tyrosine phosphorylation-dependent interactions 41 , thus precluding any direct interaction with Yap1 regulatory domains 42 . However, we previously identified an atypical complex at the lateral membrane of the adult CM formed between Ephrin-B1 and two tight junctional components, claudin-5 and Zo-1 23 . Given that Yap-1 can directly interact with Zo-1 through its PDZ binding domain, ephrin-B1 must be part of a larger complex that acts as a Yap-1 scaffolder.
Finally, we provide a new molecular mechanism with ephrin-B1 acting as a hub connecting cell morphology and proliferation. Interestingly, zebrafish retains cardiac regenerative properties through proliferation of resident CMs 43 and their ventricular CMs harbor a pseudo-rod shape (spindle-shaped) 44 , thus reminiscing ephrin-B1 defective adult-CMs but also abortive differentiated mammalian CMs as indicating by the lack of T-Tubules, a marker of lateral membrane invaginations. Whether these CMs do not express ephrin-B1 homolog is completely unknown but could be an attractive hypothesis connecting immature rod-shape CM to their proliferative benefit. Consistent with this hypothesis, round-shaped neonatal CMs proliferate and do not express ephrin-B1 predominantly at their plasma membrane 23 .
Overall, our study provided the first demonstration of the existence of a molecular scaffold at the lateral membrane of the adult CM, i.e. ephrin-B1, connecting the cell cycle arrest and morphological features of this cell. Finally, this study demonstrates that therapeutic targeting of ephrin-B1 in the adult heart could represent an attractive new strategy in regenerative cardiac medicine using resident CMs for the treatment of post-ischemic patients. stage, ephrin-B1 is complexed at the CM lateral membrane with inactive phospho-Yap1 (P-Yap1), thus preventing potential Yap1-dependent CM proliferation. B, Loss of ephrin-B1 in the adult CM releases P-Yap1 in the cytosol, leading to an unpolarized (loss of the rod-shape) but quiescent CM 23 . C, However, upon mitogenic cues (still unknown) generated in response to cardiac stress (apectomy, MI, ageing), cytosolic P-Yap-1 can be now mobilized and activated, thus leading to its translocation into the nucleus to promote the transcription of the Yap-1 target ctgf-proliferation gene and the ensuing adult CM proliferation and cardiac tissue regeneration. AAV9 mCherry S1 S30 S45 S60 S90 S105 S135 S165 S195 S210 S225 S240 S255 S285 S300 S330
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Supplementary Methods
Isolation and culture of adult CMs. Isolation of adult CMs from mice was performed using the Langendorff perfusion method as previously described (1) . After isolation, dissociated CMs were plated on laminin 2 (10 µg/ml)-coated culture dishes. After 15 min, plating medium was changed to culture medium containing MEM, 1 % penicillin-streptomycinglutamine, 1 % insulin-transferrin-selenium, 4 mM NaHCO3, 10 mM Hepes, 0.2 % BSA and 25 μM blebbistatin which was refreshed every day.
In vitro adult CM proliferation assay. Isolated adult CMs were cultured in their cell culture medium in the presence or not of 100 ng/ml neuregulin-1 (NRG-1, EGF-like domain, amino acids 176-246; R&D Systems, 396-HB-050) for 8 days. The NRG-1-containing medium was refreshed every day. For detection of DNA synthesis, 5-bromo-2-deoxyuridine labeling reagent (BrdU, 1:100 dilution, Life technologies, 00-0103) was supplemented to the culture medium every day from the second day of CM culture.
CM nucleation.
Immediately after adhesion to the laminin 2-coated plates, isolated ventricular CMs were fixed in 4 % paraformaldehyde (PFA) and co-stained with 4',6'diamidino-2-phenylindole (DAPI, Sigma Aldrich, 32670) and Oregon green® 488 conjugated Wheat-Germ-Agglutinin (WGA, Life technologies, W6748). Images were acquired on a Zeiss Observer Z.1 microscope and the nucleation profile was manually quantified using Axio Vision Rel 4.8 software.
Immunocytochemistry. CMs were fixed in ice-cold methanol fixation, permeabilized (0.1 % Triton X-100) and blocked in 1 % bovine serum albumin, CMs were immunostained using standard protocols with the following primary antibodies (all diluted in 0.1 % BSA / 0.1 % Tween 20 / 0.5 % Triton X-100 PBS) incubated overnight at 4°C: mouse anti--actinin (Sigma Aldrich, A7732), rat anti-BrdU (Abcam, ab6326), rabbit anti-aurora kinase B (Abcam, ab2254), rabbit anti-histone H3 phosphorylated at serine 10 (pH3, Cell signaling, 9701S), rabbit anti-acetyl-histone H3 (H3K9/14Ac, Millipore, 06-599), rabbit anti-tri-methyl-K9 histone H3 (H3K9me3, Abcam, ab8898), goat anti-Ephrin B1 (R&D, AF473), rabbit anti-Yap1 (Cell signaling, 14074). Cells were washed and then incubated with the corresponding secondary antibodies conjugated to specific fluorophores (Alexa-Fluor 488 goat anti-rabbit Ig-G, Alexa-fluor 594 donkey anti-rabbit IgG , Texas-red goat anti-mouse IgG or Alexa-fluor 488 donkey anti-rat IgG, Life technologies). Nuclei were visualized with DAPI (Sigma Aldrich, 32670). Fluorescent images were acquired on a Zeiss Observer Z.1 microscope with Apotome optical sectioning using Axio Vision Rel 4.8 software (Carl Zeiss). For Yap1 expression studies in isolated adult CMs, images were acquired in XYZ on a Zeiss LSM 780 confocal microscope using Zen 2011 software (Carl Zeiss).
Quantification of Yap1 activation in vitro.
Yap1 activation (nuclear translocation) was measured as the ratio of nuclear over the cytosolic Yap1 immunofluorescence pool. Nuclear to cytosolic Yap1 immunofluorescence ratio in purified CMs in culture was conducted using a Fiji home-made macro relying on both Yap1 and DAPI immunofluorescence detected in different z-stacks / cell. For each cell, only z-stacks in which nuclei were visible have been quantified individually. The results represent the ratio between quantification of nuclear Yap1 (sum of all quantified z-stacks) to cytosolic Yap1 (nuclear Yap1 subtracted to total Yap1 calculated from the sum of all quantified z-stacks). Quantifications have been selectively performed on binucleated CMs (major CM population) only to avoid bias.
Histology. Hearts were excised and immediately fixed in 10 % formalin (24 h), 4 % formalin (48 h) and then embedded in paraffin and sectioned at 6 μm intervals. Except for aging studies (transversal sections), all other heart sections were longitudinal.
Immunohistochemistry. Formalin-fixed paraffin-embedded or frozen tissues were used for immunohistochemical analysis. For paraffin-embedded sections, samples were deparaffinized, rehydrated and subjected or not to heat-induced epitope retrieval depending on the antibodies. For cryosections, samples were fixed with acetone or 4 % PFA. Heart sections were then permeabilized (0.5 % Triton X100-PBS), blocked (Dako Protein Block, Dako, X0909 or 10 % normal goat serum, Dako, X0907 or 0.5% BSA/PBS ), and stained overnight at 4°C with the following primary antibodies all diluted in 0.1 % BSA / 0.1 % Tween 20 / 0.5 % Triton X-100-PBS: rabbit anti-troponin I (Santa Cruz biotechnology, sc-15368), mouse anti-troponin T (ThermoFischer scientific, MA5-12960), rat anti-BrdU (Abcam, ab6226), rabbit anti-aurora B kinase (Abcam, ab2254) , rabbit anti-Yap1 (Cell signaling biotechnology, 4912), rabbit anti-PCM1 (Santa Cruz biotechnology, 50-164), goat anti-Ephrin-B1 (R&D, AF473), rabbit anti-phosphoYap1 (S127) (Cell signaling Technology, 4911). Secondary fluorescent antibodies used in this study were as follows: Alexa-Fluor 488 goat anti-rabbit IgG, Texas-red goat antirabbit IgG, Texas-red goat anti-mouse IgG, Alexa-Fluor 488 goat anti-mouse IgG, Alexafluor 488 donkey anti-rat IgG, Alexa-fluor 594 donkey anti-rabbit IgG, Alexa-Fluor 488 donkey anti-rabbit IgG (Life technologies). Nuclei were visualized with DAPI (Sigma Aldrich, 32670). Cell membranes were stained with Texas Red-or Alexa-fluor 633conjugated Wheat Germ Agglutinin (WGA, Life technologies, W21404). Endothelial cells were stained with OG488-conjugated Griffonia simplicifolia isolectin-B4 (Life technologies, I21411). All Images were acquired on Zeiss LSM 780 confocal microscope using Zen 2011 Software (Carl Zeiss). For Ephrin-B1/P-Yap1, colocalization images were acquired with FRAME mode.
Quantification of CM proliferation in situ.
All quantifications have been conducted in paraffin-embedded sections by confocal imaging as described above in "Immunohistochemistry" and were performed in z to ascertain the labelling in nuclei form resident CMs (Troponin T or I TnT/I-positive cells). To ascertain proliferation of resident CM, we also performed quantifications using pericentriolar material protein PCM1 , a specific CM nuclear marker (2) , despite this marker underestimates these cells as shown in SI Appendix, Fig. S3 . In most cases, we also included an additional fluorescent WGA label to mark cell borders for better appreciation of CMs. Both mitosis and cytokinesis events were visualized by the use of aurora kinase B-nuclear labeling (Aurbk+/TnT+/DAPI+ cells) or aurora kinase B labeling on cleavage furrows (non nuclear: Aurbk+/TnT+ cells) respectively since this marker is involved in both cell cycle phases (3) . Specificity of anti-aurora kinase B antibody batch was evaluated based on the use of neonatal cardiac tissue (P3) with known proliferation as positive control. Finally, all quantifications were performed by two observers blinded to the sample identity and gave similar results. 2D quantification of CM area/density. For in situ quantification of CM surface area and density, deparaffinized heart slides were stained with Texas Red-conjugated-WGA (Life technologies, W21405) and CM area and density were measured in transversal (aged mice) or longitudinal (apectomy) heart cross-sections by manually tracing the cell contour on images of whole hearts acquired on a digital slide scanner NanoZoomer (Hamamastu) using Zen 2011 software (Carl Zeiss). The experimenter was blinded to groups and genotypes.
Stereology-3D quantification of CM volume/density. Stereology analysis was conducted on 50-60 µm-thick paraffin-embedded heart sections. After deparaffinization and rehydratation, sections were permeabilized with proteinase K (S3020, 3 minutes, room temperature), blocked (Protein Block, Dako, X0909) and incubed overnight at 4°C with Oregon green® 488 conjugated Wheat-Germ-Agglutinin (WGA, Life technologies, W6748) to visualize all cell borders. Z-stack images were then acquired on a Leica TCS SP8 confocal microscope (63x oil immersion objective) up to 40-60 µm with an optimal step of 0.3 µm applying compensation of intensity loss during the z-stack acquisitions. Stereological analysis was performed using Image J software on z-stacks and brightness inversion of the AF488-WGA staining to provide clearer delimitation of CM surface. The number of CMs was counted manually (point function on Image J) on each acquired image ( 150 z-stacks). CM density was estimated as the global acquisition volume relative to the CM number. To estimate the CM volume, we proceeded first to image binarization and manual cleaning so to exclude non CM cells. The average CM volume was then estimated as the global CM volume within the image relative to the CM number. The total CM number in the heart was estimated as previously described (4) by using Nv x VREF method (NV is the estimated CM density and VREF is the reference volume of the heart). The reference volume was calculated using the tissue density of the myocardium (1.06 g/cm 3 ) (4). It should be noticed that calculation of the total CM number / heart takes into account the heart weight which can highly differ depending on the genetic background of the mouse strains(5) but also on animal housing and diet (6) . In agreement, 2-month old S129/S4 × C57BL/6 global efnb1 KO mice used in this study harbor around 150-180 mg heart weights while they are around 90-100 mg range in the C57Bl/6 mice typically used for instance by Alkass et al (7) consistent with 2 fold less CM/heart reported in their stereology study.
Analysis of cardiomyocyte cell cycle.
Cell cycle was evaluated on purified CM nuclei. Thus, isolated ventricular CMs were first fixed in ice-cold 70 % ethanol and intact nuclei were obtained from 1 mg/ml pepsin / 0.2 M HCl digestion (15 min, 37°C). After purification, nuclei were stained with 200 μg / mL propidium iodide (Life technologies, P1304MP) / 12 μg / mL RNase A (Roche)-PBS and further proceeded for FACS experiments (BD Accuri TM C6 flow cytometer and BD Accuri C6 software).
Total RNA isolation and real-time quantitative RT-PCR. Total RNA extraction from isolated CMs was performed using Trizol according to the manufacturer's instructions (TRI Reagent®, Molecular Research Center). RNA quality and quantification of extracted RNA were assessed by an Experion automated electrophoresis system (Biorad). First-strand cDNA was synthesized using the superscript II RT-PCR system (Invitrogen) with random hexamers. Negative controls without reverse transcriptase were conducted to control the absence of genomic DNA contamination. Fifteen nanograms of cDNA from RT reaction were then mixed with specific primers (listed in Supplementary Table 1 ) and EVA green mix (Euromedex). Real-time PCR was performed in 96-well plates using an ABI 7900 Fast (Applied Biosystems). Geometric mean values of GAPDH and HPRT housekeeping genes were used for normalization, as previously described (1) . Melting curve analysis was performed to ensure a single PCR product and a specific amplification. Relative gene expression was calculated using the 2 -ΔΔCT method (1) .
Lentivector constructs, transduction and evaluation of gene down-regulation. Three shRNA constructs targeting Ephrin-B1 (shefnb1) were generated by Sigma-Aldrich with the pLKO.1-puro vector. The 2 (shB1-44, -45 and -47, respectively). The shefnb1 and the control shRNA vectors (targeting luciferase, shluc, SHC007, Sigma-Aldrich) were produced using the tri-transfection procedure with the plasmids pLvPack and pLvVSVg (Sigma-Aldrich, Saint-Quentin Fallavier, France), in HEK-293FT cells. They were evaluated for their ability to transduce the C2C12 myoblast cell lines (ATCC, Catalog No. CRL-1775 TM ) and adult CM I cultures, both naturally expressing Ephrin-B1. The efficiency of cell transduction in vitro was checked in parallel by FACS analysis using the pTRIP-GFP lentivector (8) . The efficiency was at least 40 % for C2C12 cells and 99 % for adult CMs. C2C12 cells (4 x 10 4 /well) were plated into 6-well plate and transduced overnight in Dulbecco's Modified Eagle's Medium (DMEM) with 20 % fetal calf serum at 37°C with 5 % CO2 in the presence of purified concentrated lentiviral vector. Cells were transduced with 5.10 5 transduction unit (TU) of the three shenfb1 lentivectors per well or with 5.10 5 TU of the shluc lentivector as control. Primary CMs were transduced using the same protocol in their specific culture medium. The efficiency of the shefnb1 was evaluated by real-time quantitative RT-PCR (specific primers are listed in SI Appendix, Table S1 ) and promoted ~80 % efnb1 gene downregulation (not shown). For that purpose, total cellular RNA was extracted from C2C12 cells (endogenously expressing eprhin-B1) and purified using the Trizol reagent (Invitrogen) according to the manufacturer's instructions. A total of 1 µg RNA was used to synthesize cDNA using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Villebon s/ Yvette, France). Ephrin-B1 gene expression was investigated using SsoFast Eva Green Supermix (Bio-Rad) and performed on a StepOne sequence detection system (Applied Biosystems). Each reaction was run with HPRT as a reference gene and all data were normalized based on HPRT expression levels. The Yap1-expressing lentivector was obtained by subcloning the Mus musculus variant 1 Yap1 (Clone sequence: BC041733.1) in the pTRIP lentivector.
ShmiR construction and rAAV production. In the knockdown experiments in vivo, we used shmiRs as they have been reported to produce siRNAs with more efficiency than shRNAs [10] [11] [12] . Indeed shmiRs undergo a better processing and less toxicity than shRNAs. Design and construction of the shmiR targeting Ephrin-B1 was adapted from the BLOCK-iT TM PolII Mir RNAi expression system (Stratagene, Massy, France): two complementary oligonucleotides mEB1-47 Top and mEB1-47 Bottom (Supplemental Table 2 ) containing the sequence targeting mouse Ephrin-B1 with flanking regions derived from miR-155, were annealed, phosphorylated and cloned between the XbaI and BglII sites of the plasmid pAAV-MCS (Stratagene). The resulting recombinant AAV vector, rAAV-shmiRefnb1 and the control rAAV-mCherry (pAAV-MCS, Stratagene) were produced as previously described 9 by calcium phosphate tri-transfection procedure of HEK293 cells (pAAV-shmiRefnb1 or pAAV-mCherry and pAAV2/9 and pHelper (Stratagene)). The titers for the recombinant AAV9-mCherry and AAV9-shmiRefnb1 were 9.10 12 vg/ml and 1.10 13 vg/ml respectively.
MicroRNA isolation and quantification.
For miR-195 quantification, RT was performed on 500 ng of total RNA (Trizol extraction) using the miScript (Qiagen) kit. For the real-time RT-PCR reaction, the resultant cDNA was diluted 1:100. Each RTstep was performed in duplicate and the qPCR in triplicate for each reaction. U6 RNA was used as an endogenous control (primer sequences listed in Supplemental Table 1 ) and relative miR-195 (Qiagen) quantity calculated by the 2 -ΔΔCT method. MicroRNA expression was quantified by PCR using a Bio-Rad thermal-cycler. miR-195 primer sequences were purchased from Qiagen and used according to the manufacturer's protocol.
Apical resection (Apectomy). Two-month-old adult mice were anesthetized (intraperitoneal injection with 125 mg/kg ketamine plus 10 mg/kg xylazine for induction and 0.5 % O2 / 1 % isoflurane mixture inhalation for anesthesia maintenance), placed on a heating mat and subjected to artificial ventilation through endotracheal cannulation. The animals were positioned on their right side and a thoracotomy was performed on the sixth or the seventh intercostal space. After exposition of the heart apex, apical resection was controlled using a 3/8 circle needle and 8.0 polypropylene thread and performed with microscissors following the curvature of the thread to ensure surgery reproducibility (SI Appendix, Fig. S6A and Video S1). Apex resection was normalized by apex weighing (SI Appendix, Fig. S6B ). After hemostasis control, the intercostal space was closed in two separate points using a 6.0 nylon monofilament, Ethnor), followed by skin surface suture. Then, isoflurane was stopped and subcutaneous buprenorphine (100 g/kg) was administered. Mice remained air ventilated until the return of peripheral reflexes. The whole procedure was performed using an operating microscope (Zeiss OPMI 1 FC). Sham animals underwent exactly the same surgical procedure without apex resection. One day after surgery, mice that had undergone apectomy were indistinguishable from sham-operated ones. Hearts were collected 21 days following apectomy. For quantification of CM replication in cardiac tissue, BrdU was administered by intraperitoneal injection on days 1, 7 and 14 following apectomy (0.01 ml BrdU solution/g; Life technologies, 00-103).
Echocardiography.
For experiments on aged mice, animals were anesthetized by intraperitoneal injection of 10 μg/g etomidate and underwent noninvasive transthoracic echocardiography using a General Electric Vivid 7® (GE Medical System) equipped with a 14 MHz linear probe. Cardiac ventricular dimensions were measured in M-mode images at least 5 times for each animal. Left ventricle ejection fraction (LVEF) was calculated using the Teichholz formula. For apectomy and NRG-1 in vivo experiments, animals were anesthetized with a 0.5 % O2 / 1 % isoflurane mixture and underwent noninvasive transthoracic echocardiography using a Vevo® 2100 (VisualSonics). LVEF was measured in long-axis Bmode at least three times for each animal. Global longitudinal strain was measured from parasternal long-axis images using speckle-tracking-based imaging to evaluate global cardiac performance. All measurements were obtained by an examiner blinded to the genotype of the animals.
Immunoprecipitation and Western-blotting. For immunoprecipitation (IP) experiments, isolated CMs were lysed in CHAPS buffer (140 mM NaCl / 2 mM EDTA / 25 mM TrisBase, pH 7.4 / 1.5% CHAPS) while for CM protein analysis, isolated CMs were lysed in Triton buffer (150 mM NaCl / 1 mM EDTA / 50 mM TrisBase, pH 7.4 / 1% Triton X-100) both supplemented with complete protease and phosphatase inhibitors (Roche). Protein extracts were immunoprecipitated (1 mg) with anti-Ephrin-B1 (R&D, AF473) or anti-Yap1 (Cell signaling, 4912) antibodies, or directly subjected (50 µg) to SDS-PAGE and transferred into nitrocellulose membranes. Proteins were detected with primary antibodies followed by Horse Radish Peroxydase-conjugated secondary antibodies to goat, mouse, or rabbit IgG (GE Healthcare) using enhanced chemiluminescence detection reagent (GE Healthcare). Protein quantification was obtained by densitometric analysis using ImageJ software and was normalized to GAPDH expression and expressed in arbitrary units (A.U.). Due to visualization of multiple bands around expected Yap1 staining, we used positive (H9C2 overexpressing Yap1) or negative control (siRNA) to ascertain specificity of anti-Yap1 antibody.
Bioluminescence Resonance Energy Transfer (BRET). For BRET experiments, mouse
Ephrin-B1 cDNA encoding plasmid was a generous gift from A. Davy (Toulouse. France) and was C-terminally fused in frame to GFP2 in pGFP2-N3 (Perkin). Mouse Yap1 cDNA was obtained from Dharmacon (IMAGE:4239820). Yap1 was fused in frame at the N-terminus region to Renilla Luciferase (RLuc8) in modified vectors derived from pEGFP-C3 (Clontech). All plasmids were fully sequenced. BRET 2 was measured between RLuc8-and GFP2-fusion proteins following transient transfection of appropriate vectors in living HEK293T cells and in real time as previously described (9) . To control for specificity of interactions with transmembrane Ephrin-B1, we conducted BRET experiments by using instead an unrelated transmembrane CD8-GFP2 construct as previously described (9), thus recapitulating the secretory pathway distribution of Ephrin-B1 protein to test for protein crowding/collision effect that could lead to false positive BRET signals. Table S1. qRT-PCR primer sequences.
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